July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Efficient generation of laminated and light responsive retinal organoids for use in toxicological assays
Author Affiliations & Notes
  • Dean Hallam
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Gerrit Hilgen
    Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, United Kingdom
  • Birthe Dorgau
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Min Yu
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Lili Zhu
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Sanja Bojic
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Philip Hewitt
    Merck KGaA, Darmstadt, Germany
  • Michael Schmitt
    Merck KGaA, Darmstadt, Germany
  • Marianne Uteng
    Novartis, Basel, Switzerland
  • Stefan Kustermann
    University of Tübingen, F. Hoffmann-La Roche Ltd, Basel, Switzerland
  • David Steel
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Andrew Porter
    Newcastle University Protein and Proteome Analysis, Newcastle University, Newcastle Upon Tyne, United Kingdom
  • Achim Treumann
    Newcastle University Protein and Proteome Analysis, Newcastle University, Newcastle Upon Tyne, United Kingdom
  • Evelyne Sernagor
    Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, United Kingdom
  • Lyle Armstrong
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
    Newcells Biotech, Newcastle Upon Tyne, United Kingdom
  • Majlinda Lako
    Institute of Genetic Medicine , Newcastle University, Newcastle Upon Tyne, Tyne and Wear, United Kingdom
  • Footnotes
    Commercial Relationships   Dean Hallam, None; Gerrit Hilgen, None; Birthe Dorgau, None; Min Yu, None; Lili Zhu, None; Sanja Bojic, None; Philip Hewitt, None; Michael Schmitt, None; Marianne Uteng, None; Stefan Kustermann, None; David Steel, None; Andrew Porter, None; Achim Treumann, None; Evelyne Sernagor, None; Lyle Armstrong, None; Majlinda Lako, None
  • Footnotes
    Support  CRACKIT23 challenge phase 1 award (NC/CO16206/1), European Research Council (#614620), RP Fighting Blindness Innovation grant (GR584)
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5329. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dean Hallam, Gerrit Hilgen, Birthe Dorgau, Min Yu, Lili Zhu, Sanja Bojic, Philip Hewitt, Michael Schmitt, Marianne Uteng, Stefan Kustermann, David Steel, Andrew Porter, Achim Treumann, Evelyne Sernagor, Lyle Armstrong, Majlinda Lako; Efficient generation of laminated and light responsive retinal organoids for use in toxicological assays. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5329.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the variability between iPSC lines to differentiate to laminated, light responsive retinal organoids and assess their response to known neurotoxicants.

Methods : Five iPSC cell lines from patients (retinitis pigmentosa and age related macular degeneration) and unaffected subjects were differentiated to retinal organoids using three dimensional culture conditions. After 18 days in culture, the organoids were kept as pooled (6 well) or in single (96 well) conditions. High resolution scanned images were obtained to quantify the emerging retinal neuroepithelium and Retinal pigmented epithelium in each organoid; immunofluorescence and qPCR determined the cell types present, while a multi-electrode array was used for functional assays. Two known neurotoxicants, chloroquine and moxifloxacin, were applied to retinal organoids to assess their response and validate their usefulness for toxicology and pharmacology screening. The proteomic response of the organoids to both neurotoxicants was assessed utilising liquid chromatography coupled to mass spectrometry.

Results : All iPSCs generated retinal organoids (within an efficiency range of 45-89%) containing the key retinal cell types that formed functional synapses and responded to light and chemcial stimuli. We succesfully transferred this differentiation protocol to 96 well plates, whilst maintaining lamination, ultrastructural features and light responses, allowing for the scalability and automation required for toxicology and pharmacology studies. Toxicology screening for chloroquine indicated an acute response in the ganglion cell like layer and increases in proteins such as spermine synthase and Alpha-2-HS-glycoprotein. Moxifloxacin affected the photoreceptors, ganglion cells and increased secretion of proteins like Retinol binding protein 1 and Sec1 family domain-containing protein 1.

Conclusions : Our data show that light responsive retinal organoids can be generated from iPSC lines in a format which allows for easy scalability and automation, resulting in better drug discovery and delivery rates bridging the gap between compound screening and clinical trials.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×